Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy

INTRODUCTION: Current epidemiologic literature of rheumatologic immune-related adverse events (rh-irAEs) consists of clinical trials, case reports, or smaller, single-center series. We evaluate the occurrence of rh-irAEs during immune checkpoint inhibitor (ICI) therapy from US commercial claims data...

Descripción completa

Detalles Bibliográficos
Autores principales: Anjohrin, Suzanne, Sheahan, Anna, Suruki, Robert, Stark, Jeffrey L., Sloan, Victor S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572292/
https://www.ncbi.nlm.nih.gov/pubmed/34491550
http://dx.doi.org/10.1007/s40744-021-00359-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572292/
https://www.ncbi.nlm.nih.gov/pubmed/34491550
http://dx.doi.org/10.1007/s40744-021-00359-z

Ejemplares similares